SCHEMBL4411100

SCHEMBL4411100

Cc1ccc(NC(=O)c2cc(N3CCOCC3)cc(C(F)(F)F)c2)cc1-c1cc(C(=O)NC2CCN(C)CC2)on1

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 15/20 0.58
BRAF P15056 15/20 0.58
CSF1R P07333 6/20 0.58
LYN P07948 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5603601 0.95 CSF1R (0.60) RAF1BRAFCSF1R
SCHEMBL4410085 0.92 CSF1R (0.57) RAF1BRAFCSF1RLYN
SCHEMBL4408515 0.91 CSF1R (0.56) RAF1BRAFCSF1RLYN
SCHEMBL5604230 0.89 RAF1 (0.59) RAF1BRAFCSF1RLYN
SCHEMBL4410942 0.87 BRAF (0.45) RAF1BRAFCSF1R
SCHEMBL4541529 0.85 RAF1 (0.57) RAF1BRAFCSF1R
SCHEMBL4552241 0.84 RAF1 (0.63) RAF1BRAFCSF1R
SCHEMBL5593491 0.84 RAF1 (0.60) RAF1BRAFCSF1R
SCHEMBL5603594 0.84 CSF1R (0.48) RAF1BRAFCSF1R
SCHEMBL4565794 0.83 CSF1R (0.60) RAF1BRAFCSF1RLYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed